These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 39115042

  • 1. Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model.
    Wang S, Yu Z, Cao Y, Du P, Ma J, Ji Y, Yang X, Zhao Q, Hong B, Yang Y, Hai Y, Li J, Mao Y, Wu S.
    Cancer Control; 2024; 31():10732748241272713. PubMed ID: 39115042
    [Abstract] [Full Text] [Related]

  • 2. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z, Shen Y, Fan D, Liu J, Chen D, Wang K, Xu X.
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W, Tao J, Zhu W, Liu W, Anwaier A, Tian X, Su J, Shi G, Huang H, Wei G, Li C, Qu Y, Zhang H, Ye D.
    Front Immunol; 2021 Jan; 12():734646. PubMed ID: 34795663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX, Xia QD, Liu CQ, Xu JZ, Xun Y, Lu JL, Hu J, Wang SG.
    Dis Markers; 2021 Jan; 2021():8800358. PubMed ID: 34512816
    [Abstract] [Full Text] [Related]

  • 7. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
    Lu Q, Xi P, Xu S, Zhang Z, Gong B, Liu J, Zhu Q, Sun T, Zhu S, Chen R.
    Aging (Albany NY); 2024 Mar 27; 16(7):6118-6134. PubMed ID: 38546385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z, Gu Y, Yang H, Fu Q, Zhao M, Xie Y, Liu Y, Du W.
    J Cancer Res Clin Oncol; 2023 Oct 27; 149(13):11661-11678. PubMed ID: 37402968
    [Abstract] [Full Text] [Related]

  • 11. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z, Li T, Xiao C, Zou S, Zhang M, Zhang Q, Wang Z, Zhan H, Wang H.
    World J Surg Oncol; 2022 Apr 14; 20(1):120. PubMed ID: 35422048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.
    Xu W, Liu WR, Xu Y, Tian X, Anwaier A, Su JQ, Zhu WK, Shi GH, Wei GM, Huang YP, Qu YY, Zhang HL, Ye DW.
    Int J Biol Sci; 2021 Apr 14; 17(9):2205-2222. PubMed ID: 34239350
    [Abstract] [Full Text] [Related]

  • 16. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z, Deng T, Duan X, Zeng G.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32789468
    [Abstract] [Full Text] [Related]

  • 17. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S, Xu X, Wang Y, Zhu Y, Wang J, Wang H, Guo J.
    Ann Clin Lab Sci; 2021 Sep 30; 51(5):597-608. PubMed ID: 34686501
    [Abstract] [Full Text] [Related]

  • 18. The Expression and Prognostic Value of Co-stimulatory Molecules in Clear Cell Renal Cell Carcinoma (CcRcc).
    Wu C, Cai X, He C.
    Comb Chem High Throughput Screen; 2024 Sep 30; 27(2):335-345. PubMed ID: 37171001
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.